EyeSpy.org Logo
  • Directory
  • Events
  • News
  • Media
  • About
  • Contact
Donate
EyeSpy.org Logo
  • Home
  • Directory
  • Events
  • News
  • Media
  • Contact Us
  • Donate
USH2A-Associated Retinitis Pigmentosa in Koreans: Molecular Genetics and Clinical Characteristics

USH2A-Associated Retinitis Pigmentosa in Koreans: Molecular Genetics and Clinical Characteristics

Sep 3, 2026 | Government, News, Science

Am J Ophthalmol. 2026 Sep 3:S0002-9394(26)00501-5. doi: 10.1016/j.ajo.2026.08.044. Online ahead of print.ABSTRACTPURPOSE: To describe the molecular genetic spectrum and age-related clinical features of USH2A-associated retinitis pigmentosa in Korean patients.DESIGN:...
USH2A-Associated Retinitis Pigmentosa in Koreans: Molecular Genetics and Clinical Characteristics

Deuterated Vitamin A for Stargardt Disease in TEASE-1 Trial

Sep 3, 2026 | Government, News, Science

JAMA Ophthalmol. 2026 Sep 3. doi: 10.1001/jamaophthalmol.2026.3926. Online ahead of print.NO ABSTRACTPMID:42690644 | DOI:10.1001/jamaophthalmol.2026.3926
USH2A-Associated Retinitis Pigmentosa in Koreans: Molecular Genetics and Clinical Characteristics

Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease: The TEASE-1 Randomized Clinical Trial

Sep 3, 2026 | Government, News, Science

JAMA Ophthalmol. 2026 Sep 3:e263662. doi: 10.1001/jamaophthalmol.2026.3662. Online ahead of print.ABSTRACTIMPORTANCE: Stargardt disease (STGD) is the most common macular dystrophy, resulting in profound loss of vision. There is no approved treatment.OBJECTIVE: To...
USH2A-Associated Retinitis Pigmentosa in Koreans: Molecular Genetics and Clinical Characteristics

Pathological Retinal Oscillations across Retinal Diseases: Shared Circuit Mechanisms and Implications for Photopsia

Sep 2, 2026 | Government, News, Science

Biol Pharm Bull. 2026;49(9):1371-1375. doi: 10.1248/bpb.b26-00363.ABSTRACTRetinitis pigmentosa (RP) is an inherited retinal disorder characterized by the progressive degeneration of photoreceptor cells, representing a leading cause of blindness. A substantial...
USH2A-Associated Retinitis Pigmentosa in Koreans: Molecular Genetics and Clinical Characteristics

Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain

Aug 31, 2026 | Government, News, Science

N Engl J Med. 2026 Aug 29. doi: 10.1056/NEJMoa2608903. Online ahead of print.ABSTRACTBACKGROUND: Many patients with suspected acute coronary syndrome in whom myocardial infarction has been ruled out in the emergency department remain at risk for cardiovascular events....
USH2A-Associated Retinitis Pigmentosa in Koreans: Molecular Genetics and Clinical Characteristics

Mesenchymal drift in ciliopathy iPSC-derived RPE reveals a convergent pathogenic cell state

Aug 29, 2026 | Government, News, Science

Cell Rep. 2026 Aug 28;45(9):117906. doi: 10.1016/j.celrep.2026.117906. Online ahead of print.ABSTRACTCiliopathies comprise a spectrum of disorders involving mutations in over 150 genes affecting the primary cilium, with retinal degeneration as a prominent feature...
« Older Entries
Next Entries »

Recent Posts

  • Sight Savers America Receives Grant from the Tri-City Community Foundation, an Affiliate of The Community Foundation of South Alabama
  • Blind Children’s Center Partners with Children’s Hospital Los Angeles to Expand Care for Children With CVI
  • Nanoscope’s investigational RP treatment MOGENRY advances toward FDA approval
  • All About Accessibility
  • Call for Nominations: Athlete Advisory Council Nominations

Recent Comments

No comments to show.

About

The Eye Spy Foundation, a 501(c)(3) non-profit, is dedicated to enhancing digital accessibility for the blind and low-vision community, fostering empowerment and connection through innovative web solutions.

Links

$

Directory

$

News

$

Events

$

Media

Connect



1-844-222-8848



team@eyespy.org

l

Contact Us

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Give

Donate
Eye Spy Foundation Logo

Copyright © 2024 – Current |Eye Spy Foundation.